Bodor Laboratories, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
6
Ending by 2030
Jan 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 2, 2027The maintenance fee for Use of selected anticholinergic zwitterions (US 10,335,367) comes due Jan 2, 2027. Unpaid by Jul 2, 2027, it lapses early.
- 1 fee due Feb 20, 2027The maintenance fee for Method of dosing and use of soft anticholinergic esters (US 10,383,846) comes due Feb 20, 2027. Unpaid by Aug 20, 2027, it lapses early.
- 1 fee due Jun 29, 2027The maintenance fee for Method of dosing and use of soft anticholinergic esters (US 9,220,707) comes due Jun 29, 2027. Unpaid by Dec 29, 2027, it lapses early.
- 2 fees due Oct 9 to 28, 2027 · next Oct 9
Recent changes
- 6 terms have ended since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,560,448 | Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application In force · From the USPTO record | In force | From the USPTO record | |
| US 8,568,699 | Soft Anticholinergic Zwitterions In force · Medium confidence | In force | Medium confidence | |
| US 8,071,639 | Soft anticholinergic zwitterions In force · From the USPTO record | In force | From the USPTO record | |
| US 8,147,809 | Soft anticholinergic esters In force · From the USPTO record | In force | From the USPTO record | |
| US 7,691,811 | Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye In force · From the USPTO record | In force | From the USPTO record | |
| US 7,687,484 | Transporter enhanced corticosteroid activity In force · From the USPTO record | In force | From the USPTO record | |
| US 9,220,707 | Method of dosing and use of soft anticholinergic esters In force · From the USPTO record | In force | From the USPTO record | |
| US 9,492,429 | Method of dosing and use of soft anticholinergic esters In force · From the USPTO record | In force | From the USPTO record | |
| US 9,895,350 | Method of dosing and use of soft anticholinergic esters In force · From the USPTO record | In force | From the USPTO record | |
| US 10,383,846 | Method of dosing and use of soft anticholinergic esters In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 33: 2 lapsed for an unpaid fee · 3 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 8 no status recorded